ResApp Health Limited (“Company”) hereby requests that its securities be placed in a trading
halt and provides the following information in accordance with ASX Listing Rule 17.1.
The Company requests a trading halt immediately, pending the release of an announcement regarding an update on the Company’s partnership with a leading humanitarian organization.
The trading halt is to last until the earlier of the Company releasing the announcement, or the commencement of trading on Wednesday 10 May 2017.
RAP Price at posting:
30.5¢ Sentiment: Buy Disclosure: Held